slides · global inventory
Disclaimer
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,127
Current window 30,781-30,810
Pages 1,371
Rows per page 30
Component
30,781-30,810 of 41,127
03
Azerion | Results Presentation Deck | 19 slidesAzerion | Results Presentation Deck | 19 slides · Azerion
Conference presentation Investor relations 1 hit
04
The slide uses a two-column layout to contrast strategic milestones with quantitative financial results.Azerion | Results Presentation Deck | 19 slides · Azerion
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
18
The slide uses a split-layout comparing qualitative strategic achievements with quantitative financial KPIs.Azerion | Results Presentation Deck | 19 slides · Azerion
Conference presentation Investor relations 1 hit
02
Bausch Health Companies | Results Presentation Deck | 48 slidesBausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
03
Bausch Health Companies | Results Presentation Deck | 48 slidesBausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
07
Unconsolidated revenue change vs 2Q22, in millions USD. Includes non-GAAP organic growth metrics.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · Attention1 hit
11
Includes revenue figures in millions USD and percentage growth metrics.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
13
Includes reported vs organic growth metrics and segment-specific revenue drivers.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
18
Includes a highlight box indicating no debt maturities until 2025.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
21
The slide uses stacked bar charts to represent the split between B+L and BHC (excl. B+L) segments.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
32
The slide provides a breakdown of segment performance for Bausch Health.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
36
The table provides a detailed breakdown of various non-GAAP adjustments including amortization, impairments, and restructuring costs.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
37
Includes a secondary table for noncontrolling interest adjustments.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
38
The table includes adjustments for foreign exchange rates, acquisitions, and divestitures to arrive at organic revenue figures.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
39
The table includes adjustments for exchange rates, acquisitions, and divestitures to arrive at organic revenue figures.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
40
The table provides a bridge between reported operating cash flow and adjusted cash flow by adding back various non-recurring or specific costs.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
41
The table breaks down adjustments for legal settlements, transformation costs, separation/IPO costs, interest payments, and exchange fees.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
07
The slide uses a timeline-based progression (2023 -> Proof of Value -> Platform Innovation) mapped against product generations.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
21
The slide presents a financial bridge/reconciliation of guidance metrics.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations Beat · Financials1 hit
25
The slide presents two distinct tables side-by-side. The data is presented in millions of USD.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations 1 hit
16
Bigbear AI | Investor Presentation Deck | 29 slidesBigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations Beat · Financials1 hit
20
Includes footnotes regarding GAAP reconciliation and pro forma comparisons.Bigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations Beat · Financials1 hit
21
Bigbear AI | Investor Presentation Deck | 29 slidesBigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations 1 hit
02
BioAtla | Investor Presentation Deck | 43 slidesBioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
The slide uses a three-column layout to categorize the platform's application, each with a corresponding antibody diagram.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Solution1 hit
08
The slide uses a horizontal bar chart integrated into a table to represent clinical trial phases.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Solution1 hit
10
The slide uses a structured list format to define the target market and unmet medical need.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Market SizeLoop · Quick Win Big Bet1 hit
13
Includes clinical trial design details (dosing regimens, patient counts, endpoints).BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Market SizeLoop · Quick Win Big Bet1 hit
20
Includes waterfall plot (left) and spider plot (right) for patient response data.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
23
Includes abbreviations for indications (LMS, UPS, NSCLC) and trial design details.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit